Solaris Endovascular, Inc. announced that the DEScover clinical trial has completed enrollment. According to the company, th ...
Enrollment milestone achieved ahead of schedule as Solaris DE drug-eluting continues to gather additional clinical ...
Investor's Business Daily on MSN
Data center power provider bolts higher, nearing a buy point
This data center power provider is climbing in a consolidation pattern and nearing a prior high. Analysts see 135% profit ...
Revenue of $167 million increased 12% sequentially from second quarter 2025 due to activity growth within the Solaris Power Solutions segment. Net income of $25 million and $0.31 per diluted Class A ...
The share price of Solaris Energy Infrastructure, Inc. (NYSE:SEI) surged by 14.64% between December 30, 2025, and January 6, ...
HOUSTON--(BUSINESS WIRE)--Solaris Energy Infrastructure, Inc. (“Solaris” or the “Company”) (NYSE: SEI) today announced the pricing of its underwritten public offering of 6,500,000 shares of its Class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback